Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q2- Text added to 2021 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
acute, AEs, allergic, anemia, bacteremia, Baseline, Cantor, CI, CRABC, cure, diarrhea, endpoint, Fitzgerald, HABP, hypersensitivity, hypokalemia, injury, kidney, liability, nephrotoxicity, noncash, objective, observed, polymyxin, population, randomized, reduction, RIFLE, stage, statistically, suggested, Test, tested, TOC, VABP, VP
Valuein 2021 Q2 filing- Value in 2021 Q3 filing
Original filings
Filing view